Corroborating this suggestion that the association between IL-13 and IL-17 can improve the conditions to promote SIgA production in COVID-19 patients, including two months after SARS-CoV-2 infection, we found that the COVID-19 group without SIgA did not show this same association. The gene discussed is IL17A; the disease is COVID-19.